Related Experiment Video

Updated: Jun 8, 2026

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay
05:17

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Published on: February 9, 2021

Synthesis and biological evaluation of 2-phenylthiazole-4-carboxamide derivatives as anticancer agents

Alireza Aliabadi1, Fazel Shamsa, Seyed Nasser Ostad

  • 1Department of Medicinal Chemistry, Faculty of Pharmacy and Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran 14174, Iran.

European Journal of Medicinal Chemistry
|September 18, 2010
PubMed

Insights

Researchers developed novel 2-phenylthiazole-4-carboxamide derivatives as potential cancer treatments. Certain derivatives showed significant cytotoxic activity against breast, colorectal, and colon cancer cell lines.

Area of Science:

  • Medicinal Chemistry
  • Organic Synthesis
  • Cancer Research

Background:

  • Novel cytotoxic agents are crucial for cancer therapy.
  • 2-phenylthiazole-4-carboxamide scaffolds are explored for biological activity.

Purpose of the Study:

  • Synthesize and evaluate novel substituted 2-phenylthiazole-4-carboxamide derivatives.
  • Investigate the structure-activity relationships (SAR) of these compounds against human cancer cell lines.

Main Methods:

  • Synthesis of a series of substituted 2-phenylthiazole-4-carboxamide derivatives.
  • In vitro evaluation of cytotoxic activity against T47D (breast), Caco-2 (colorectal), and HT-29 (colon) cancer cell lines.
  • Structure-activity relationship analysis based on substituent modifications.

Main Results:

  • Specific methoxy substitutions enhanced activity against Caco-2 cells.
  • 2-methoxy substituents maintained high activity against HT-29 and T47D cells.
  • A 3-fluoro analog demonstrated potent cytotoxic activity across all tested cell lines (IC50 < 10 μg/mL).

Conclusions:

  • Substituted 2-phenylthiazole-4-carboxamides are promising cytotoxic agents.
  • Strategic modifications of the arylacetamido moiety significantly impact anticancer activity.
  • The 3-fluoro analog warrants further investigation as a potential anticancer drug candidate.

More Related Videos

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay11:14

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay

Published on: November 10, 2013

Related Concept Videos

Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists01:29

Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists

Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...